Cochrane Abstracts
Acetyl‐L‐carnitine for patients with hepatic encephalopathy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Acetyl‐L‐carnitine for Patients With Hepatic Encephalopathy." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434010/all/Acetyl‐L‐carnitine_for_patients_with_hepatic_encephalopathy.
Acetyl‐L‐carnitine for patients with hepatic encephalopathy. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434010/all/Acetyl‐L‐carnitine_for_patients_with_hepatic_encephalopathy. Accessed February 8, 2025.
Acetyl‐L‐carnitine for patients with hepatic encephalopathy. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434010/all/Acetyl‐L‐carnitine_for_patients_with_hepatic_encephalopathy
Acetyl‐L‐carnitine for Patients With Hepatic Encephalopathy [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434010/all/Acetyl‐L‐carnitine_for_patients_with_hepatic_encephalopathy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Acetyl‐L‐carnitine for patients with hepatic encephalopathy
ID - 434010
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434010/all/Acetyl‐L‐carnitine_for_patients_with_hepatic_encephalopathy
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
